![Jun Okada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jun Okada
President at 3-D MATRIX, LTD.
Net worth: 177 545 $ as of 29/06/2024
Profile
Jun Okada is currently the President & Representative Director at 3-D Matrix Ltd.
He is also a Director at 3-D Matrix, Inc., 3-D Matrix Da America Latina Representacão Comercial Ltda., 3-D Matrix Asia Pte.
Ltd., 3-D Matrix Europe SAS, and Beijing 3-D Matrix Investment Consulting, Ltd.
Mr. Okada has an MBA from INSEAD and a graduate degree from the University of Tokyo Faculty of Law & Graduate Schools for Law.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
3-D MATRIX, LTD.
0.25% | 29/04/2023 | 204,000 ( 0.25% ) | 177 545 $ | 29/06/2024 |
Jun Okada active positions
Companies | Position | Start |
---|---|---|
3-D MATRIX, LTD. | President | 29/02/2016 |
3-D Matrix Asia Pte. Ltd. | Director/Board Member | 30/09/2012 |
3-D Matrix Da America Latina Representacão Comercial Ltda.
![]() 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Director/Board Member | 31/05/2014 |
Beijing 3-D Matrix Investment Consulting, Ltd. | Director/Board Member | 31/07/2014 |
3-D Matrix Europe SAS
![]() 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Director/Board Member | 31/03/2012 |
3-D Matrix, Inc. | Director/Board Member | 31/03/2016 |
Training of Jun Okada
INSEAD | Masters Business Admin |
University of Tokyo Faculty of Law & Graduate Schools for Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
3-D MATRIX, LTD. | Health Technology |
Private companies | 5 |
---|---|
3-D Matrix Asia Pte. Ltd. | |
3-D Matrix Da America Latina Representacão Comercial Ltda.
![]() 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Health Technology |
Beijing 3-D Matrix Investment Consulting, Ltd. | |
3-D Matrix Europe SAS
![]() 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Health Technology |
3-D Matrix, Inc. |
- Stock Market
- Insiders
- Jun Okada